# A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Normal Hepatic Function and Participants With Hepatic Impairment

> clinical trial · VERIFIED · 2026-08-11

Status: RECRUITING · Sponsor: Insmed Incorporated · Condition: Hepatic Impairment

- Company: Insmed Incorporated
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT07643155

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.